Deborah K. Mayer

Deborah K. Mayer

Auto-generated profile, based on publicly available information

Deborah K. Mayer

School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
DMDeborah K. Mayer
Deborah K. Mayer
DTDebbie Travers
Debbie Travers
AWAnnah Wyss
Annah Wyss
ALAshley Leak
Ashley Leak
AWAnna Waller
Anna Waller
Purpose: Emergency departments (EDs) in the United States are used by patients with cancer for disease or treatment-related problems and unrelated issues. The North Carolina Disease Event Tracking and Epidemiologic Collection Tool (NC DETECT) collects information about ED visits through a statewide database.Patients and Methods: After approval by the institutional review board, 2008 NC DETECT ED visit data were acquired and cancer-related visits were identified. Descriptive statistics and logistic regressions were performed. Of 4,190,911 ED visits in 2008, there were 37,760 ED visits by 27,644 patients with cancer.Results: Among patients, 77.2% had only one ED visit in 2008, the mean age was 64 years, and there were slightly more men than women. Among visits, the payor was Medicare for 52.4% and Medicaid for 12.1%. More than half the visits by patients with cancer occurred on weekends or evenings, and 44.9% occurred during normal hours. The top three chief complaints were related to pain, respiratory distress, and GI issues. Lung, breast, prostate, and colorectal cancers were identified in 26.9%, 6.3%, 6%, and 7.7% of visits, respectively, with diagnosis. A total of 63.2% of visits resulted in hospital admittance. When controlling for sex, age, time of day, day of week, insurance, and diagnosis position, patients with lung cancer were more likely to be admitted than patients with other types of cancer.Conclusion: To the best of our knowledge, this is the first study to provide a population-based snapshot of ED visits by patients with cancer in North Carolina. Efforts that target clinical problems and specific populations may improve delivery of quality cancer care and avoid ED visits.

1 January 2017 in The Lancet Oncology
Verified
Journal Article
Closed access
DMDeborah K Mayer
Deborah K Mayer
SNShelly Fuld Nasso
Shelly Fuld Nasso
JEJo Anne Earp
Jo Anne Earp

11 June 2020 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
Doris HowellDoris Howell
Doris Howell
DMDeborah K Mayer
Deborah K Mayer
RFRichard Fielding
Richard Fielding
MEManuela Eicher
Manuela Eicher
ILIrma M. Verdonck-de Leeuw
Irma M. Verdonck-de Leeuw
TCthe Global Partners for Self-Management in Cancer
the Global Partners for Self-Management in Cancer
Individuals with cancer and their families assume responsibility for management of cancer as an acute and chronic disease. Yet, cancer lags other chronic diseases in its provision of proactive self-management support in routine, everyday care leaving this population vulnerable to worse health status, long-term disability, and poorer survival. Enabling cancer patients to manage the medical and emotional consequences and lifestyle and work changes due to cancer and treatment is essential to optimizing health and recovery across the continuum of cancer. In this paper, the Global Partners on Self-Management in Cancer puts forth six priority areas for action: Action 1: Prepare patients and survivors for active involvement in care; Action 2: Shift the care culture to support patients as partners in cocreating health and embed self-management support in everyday health-care provider practices and in care pathways; Action 3: Prepare the workforce in the knowledge and skills necessary to enable patients in effective self-management and reach consensus on core curricula; Action 4: Establish and reach consensus on a patient-reported outcome system for measuring the effects of self-management support and performance accountability; Action 5: Advance the evidence and stimulate research on self-management and self-management support in cancer populations; Action 6: Expand reach and access to self-management support programs across care sectors and tailored to diversity of need and stimulation of research to advance knowledge. It is time for a revolution to better integrate self-management support as part of high-quality, person-centered support and precision medicine in cancer care to optimize health outcomes, accelerate recovery, and possibly improve survival.

1 November 2014 in Journal of Oncology Practice
Verified
Journal Article
Closed access
PDF file
DMDeborah K. Mayer
Deborah K. Mayer
LNLarissa Nekhlyudov
Larissa Nekhlyudov
CSClaire F. Snyder
Claire F. Snyder
JMJanette K. Merrill
Janette K. Merrill
DWDana S. Wollins
Dana S. Wollins
LSLawrence N. Shulman
Lawrence N. Shulman
Once SCPs are adopted on a wider scale, their value for improving the process of survivorship care planning should be evaluated, and other questions regarding improved outcomes can be addressed by research and implementation studies.

23 September 2014 in Cancer
Verified
Journal Article
Open access
PDF file
DMDeborah K. Mayer
Deborah K. Mayer
SBSarah A. Birken
Sarah A. Birken
DCDevon K. Check
Devon K. Check
RCRonald C. Chen
Ronald C. Chen
In 2006, the Institute of Medicine recommended that cancer survivors who are completing primary treatment receive a survivorship care plan (SCP) based on face validity. The state of scientific knowledge regarding the SCP is unclear. The authors conducted an integrative review of existing evidence regarding SCPs. The MEDLINE/PubMed database, the Excerpta Medica Database (EMBASE), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) database were searched for relevant studies published between 2006 and 2013 using a combination of keywords: “survivors,” “survivorship,” “care plans,” “care planning,” “treatment summaries,” and “cancer.” Articles were included if they 1) reported results from an empirical study, 2) included cancer survivors who were diagnosed at age ≥18 years, 3) related to SCP, and 4) were published in English. In total, 781 records were retrieved; 77 were identified as duplicates, and 665 were abstracts or presentations that did not relate to SCPs for adults or were not empirical, which left 42 articles for inclusion in this review. Studies regarding SCP fell into 3 categories: 1) content (n=14), 2) dissemination and implementation (n=14), and 3) survivor and provider outcomes (n=14). SCPs have been endorsed and are associated with improved knowledge, but SCP use remains sporadic. Only 4 studies were randomized controlled trials (RCTs) that avoided many biases associated with observational studies. Other limitations included cross‐sectional or pre‐SCP–post‐SCP (“pre‐post”) designs, limited generalizability caused by a lack of sample diversity, and a lack of systematic testing of data‐collection tools. The quantity and quality of SCP research are limited. SCPs have been endorsed, but evidence of improved outcomes associated with SCP is limited. Future research that addresses the methodological concerns of extant studies is needed regarding SCP use, content, and outcomes. Cancer 2015;121:978–996. © 2014 American Cancer Society.

31 August 2011 in The Oncologist
Verified
Journal Article
Closed access
WIWilliam Irvin
William Irvin
HMHyman B. Muss
Hyman B. Muss
DMDeborah K. Mayer
Deborah K. Mayer
Approximately 40,000 women die as a result of breast cancer each year and many more live with advanced disease. When breast cancer recurs, the goals of treatment often shift from one of cure to controlling the disease for as long as possible while palliating symptoms interfering with the patient's functional status and quality of life. This requires ongoing discussions with the patient and family about the goals of care. Many symptoms depend on the site of metastasis, with bone being the most frequent, and commonly occur with fatigue, depression, insomnia, and pain. The purpose of this paper is to identify and provide an overview of the management of the most common symptoms in patients with breast cancer metastases.